GreggJonathanBerdyMDF.A.C.S.

PubMed

• The impact of Demodex blepharitis on patient symptoms and daily life.
  Melissa Barnett, Blake Simmons, Patrick Vollmer, Assem Patel, Paul Karpecki, Mark Holdbrook, Stephanie N Baba, William E Whitson, Gregg J Berdy, Laura M Periman, John ...> ;Optometry and Vision Science. 2024 Mar 1
• Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.
  Simmons, B., Gaddie, I., Holdbrook, M., Baba, S., Jalalat, P., Sadri, E., Paauw, J., Ciolino, J., Nijm, L., Meyer, J., Berdy, G., Yeu, E.> ;Cornea. 2024 Feb 9
• Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO).
  Massaro-Giordano, M., Goisis, G., Pasedis, G., Mantelli, F., Hamrah, P., Schanzlin, D., Holland, E., Berdy, G.> ;Ophthalmology and Therapy. 2024 Feb 1
• 6 citations
  Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).
  Ian Benjamin Gaddie, Eric D Donnenfeld, Paul Karpecki, Patrick Vollmer, Gregg J Berdy, Jared D Peterson, Blake Simmons, Aimée R P Edell, William E Whitson, Joseph B Ci...> ;Ophthalmology. 2023 Oct 1
• 22 citations
  NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study.
  Joseph Tauber, Gregg J Berdy, David L Wirta, Sonja Krösser, Jason L Vittitow> ;Ophthalmology. 2023 May 1
• 9 citations
  Lirentelimab for severe and chronic forms of allergic conjunctivitis.
  Stephen D Anesi, Joseph Tauber, Quan Dong Nguyen, Peter Chang, Gregg J Berdy, Charles C Lin, David S Chu, H Terry Levine, Andrew D Fernandez, Neeta Roy, Penny A Asbell...> ;The Journal of Allergy and Clinical Immunology. 2022 Sep 1
• 2 citations
  The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular ...
  John A Hovanesian, Andrew Keyser, Gregg Berdy, Robert Sorensen> ;Clinical Ophthalmology. 2022 Jan 1
• 8 citations
  Effect of Cyclosporine 0.09% Treatment on Accuracy of Preoperative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery.
  John A. Hovanesian, Gregg J. Berdy, Alice T Epitropoulos, Jack T. Holladay> ;Clinical Ophthalmology. 2021 Sep 1
• 15 citations
  An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial
  Laura E Downie, Milton M Hom, Gregg J. Berdy, Sherif El-Harazi, Anthony Verachtert, Jacqueline Tan, Haixia Liu, Cindy Carlisle-Wilcox, Peter A. Simmons, Joseph G. Vehige> ;The Ocular Surface. 2020 Jan 1
• 21 citations
  Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
  Christopher Lievens, Gregg J. Berdy, David Douglass, Stephen Montaquila, Hugh Lin, Peter A. Simmons, Cindy Carlisle-Wilcox, Joseph G. Vehige, Sameena Haque> ;Contact Lens & Anterior Eye. 2019 Aug 1
• 89 citations
  Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning.
  Alice T Epitropoulos, Cynthia Matossian, Gregg J. Berdy, Ranjan P. Malhotra, Richard Potvin> ;Journal of Cataract and Refractive Surgery. 2015 Aug 1
• 13 citations
  Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigat...
  Ranjan P. Malhotra, Joseph P Gira, Gregg J. Berdy, Robert C. Brusatti> ;Clinical Ophthalmology. 2012 Jun 5
• 3 citations
  Ocular allergic disorders: disease entities and differential diagnoses.
  Gregg J. Berdy, Susan S. Berdy> ;Current Allergy and Asthma Reports. 2009 Jul 24
• 15 citations
  Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis.
  Stephen V. Scoper, Gregg J. Berdy, Steven J. Lichtenstein, Jay M. Rubin, Marc Bloomenstein, Robert E. Prouty, Cullen T. Vogelson, Michael R. Edwards, Curtis Waycaster,...> ;Advances in Therapy. 2007 Nov 1
• 51 citations
  Correction of Large Amblyopiogenic Refractive Errors in Children Using the Excimer Laser
  Lawrence Tychsen, Eric Packwood, Gregg J. Berdy> ;Journal of AAPOS. 2005 Jun 1
• 36 citations
  Blood Concentrations of Cyclosporin A During Long-Term Treatment With Cyclosporin A Ophthalmic Emulsions in Patients With Moderate to Severe Dry Eye Disease
  David Small, Andrew Acheampong, Brenda Reis, Katherine Stern, William C. Stewart, Gregg J. Berdy, Randy Epstein, Robert Foerster, Lance Forstot, Diane D.-S. Tang-Liu> ;Journal of Ocular Pharmacology and Therapeutics. 2002 Oct 1
• 18 citations
  Pemirolast Potassium 0.1% Ophthalmic Solution is an Effective Treatment for Allergic Conjunctivitis: A Pooled Analysis of Two Prospective, Randomized, Double-masked, P...
  Mark B. Abelson, Gregg J. Berdy, Thomas K. Mundorf, Lawrence D. Amdahl, Adrienne L. Graves> ;Journal of Ocular Pharmacology and Therapeutics. 2002 Oct 1
• 30 citations
  Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the ...
  Gregg J. Berdy, Juan O. Stoppel, Arthur B. Epstein> ;Clinical Therapeutics. 2002 Jun 1
• 2 citations
  Gastroesophageal Reflux Disease Presenting as Xerophthalmia
  Bradley V. Davitt, Gregg J Berdy, Robert E Kane> ;Journal of Pediatric Ophthalmology and Strabismus. 2001 Sep 1
• 44 citations
  Evaluation of the efficacy of olapatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen ch...
  Dennis L. Spangler, George Bensch, Gregg J. Berdy> ;Clinical Therapeutics. 2001 Aug 1
• 3 citations
  Ocular allergic disease in the senior patient: diagnosis and management.
  Gregg J. Berdy> ;Allergy and Asthma Proceedings. 2000 Sep 1
• 55 citations
  A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution ...
  Gregg J. Berdy, Dennis L. Spangler, George Bensch, Susan S. Berdy, Robert C. Brusatti> ;Clinical Therapeutics. 2000 Jul 1
• 3 citations
  The effects of systemic medication on ocular allergic disease.
  Gregg J. Berdy> ;Acta Ophthalmologica Scandinavica. Supplement. 2000 Jun 1
• 20 citations
  Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management.
  Gregg J. Berdy, Bo Hedqvist> ;Acta Ophthalmologica Scandinavica. Supplement. 2000 Jun 1
• Atopic keratoconjunctivitis (AKC).
  Berdy, G. J.> ;Acta Ophthalmol Scand Suppl. 1999
• Join now to see all

Journal Articles

• Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning  
  Epitropoulos, A.T., Matossian,C., Berdy, G.J., Malhotra, R.P. and Potvin, R., J. Cataract Refract. Surg., 1/1/2015
• Safety of besifloxacin ophthalmic suspension 06% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigato...  
  Malhotra, R., Gira, J., Berdy, G.J., and Brusatti, R., Clin. Ophthalmol., 1/1/2012
• Ocular allergic disorders: disease entities and differential diagnoses  
  Berdy, G.J. and Berdy, S.S., Curr. Allergy Asthma Rep., 1/1/2009
• Allergic conjunctivitis: new strategies for treatment  
  Berdy, G.J., Advanced Ocular Care, 1/1/2009
• Perception and quality of life associated with the use of Olopatadine 02% (Pataday) in patients with active allergic conjunctivitis  
  Scoper, S.V., Berdy, G.J., Lichtenstein, S.J., Rubin, J.M., Bloomenstein, M, Prouty, R.E.,Vogelson, C.T., Edwards, M.R., Waycaster, C., Pasquine, T., Gross, R.D. and R..., Advances in Therapy, 1/1/2007
• Correction of large amblyopiogenic Refractive errors in children using the excimer laser  
  Tychsen, L., Packwood, E. and Berdy, G. J., J. Am. Assoc. Ped. Ophthalmol. Strab., 1/1/2005
• Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 01% ophthalmic solution and loteprednol etabonate 02% ophthalmic suspension in the co...  
  Berdy, G.J., Stoppel, J.O. and Epstein, A.B., Clin. Therapeutics., 1/1/2002
• Blood concentrations of cyclosporin A during long-term treatment with cyclosporin A ophthalmic emulsion in patients with moderate to severe dry eye disease  
  Small, D.S., Acheampong, A., Reis, B., Stern, K., Stewart, W., Berdy, G. J., Epstein, R., Foerster, R., Forstot, L. and Tang-Liu, D.D., J. Ocular. Pharm. Therapeutics., 1/1/2002
• Pemirolast potassium 01% ophthalmic solution is an effective treatment for allergic conjunctivitis: A pooled analysis of two prospective, randomized, double-masked, pl...  
  Abelson, M.B., Berdy, G.J., Mundorf, T., Amdahl, L.D., Graves, A.L. and The Pemirolast Study Group, J. Ocular. Pharm. Therapeutics., 1/1/2002
• Gastroesophageal reflux disease presenting as xerophthalmia  
  Davitt, B.V., Berdy, G.J. and Kane, R.E., Ped. Ophthalmol. And Strab., 1/1/2001
• Evaluation of the efficacy of olopatadine hydrochloride 01% ophthalmic solution and azelastine hydrochloride 005% ophthalmic solution in the conjunctival antigen chall...  
  Spangler, D.L., Bensch G. and Berdy, G.J., Clin. Therapeutics., 1/1/2001
• A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 01% ophthalmic solution and ketotifen fumarate 0025% ophthalmic solution in...  
  Berdy,G.J., Spangler, D.L., Bensch, G., Berdy, S.S. and Brusatti, R.C., Clin Therapeutics, 1/1/2000
• Ocular allergic disease in the senior patient: diagnosis and management  
  Berdy, G.J., Allergy and Asthma Proceeding, 1/1/2000
• The effects of systemic medication on ocular allergic disease  
  Berdy, G.J., Acta Ophthalmol. Scandin., 1/1/2000
• Ocular allergic disorders and dry eye disease: Associations, diagnostic dilemmas and management  
  Berdy, G.J. and Hedqvist, B., Acta Ophthalmol. Scandin., 1/1/2000
• Atopic Keratoconjunctivitis  
  Berdy, G.J., Acta Ophthalmol. Scandin., 1/1/1999
• Angle closure glaucoma precipitated by atropine (reply)  
  Berdy, G. and Kolker, A., Arch. Intern. Med., 1/1/1992
• Preservative-free artificial tear preparations: assessment of corneal epithelial toxic effects  
  Berdy, G.J., Abelson, M.B., Smith, L.M. and George, M.A., Arch. Ophthalmol., 1/1/1992
• Angle closure glaucoma precipitated by aerosolized atropine  
  Berdy, G.J., Berdy, S.S., Odin, L.S. and Hirst, L.W., Arch. Intern. Med., 1/1/1991
• Allergic conjunctivitis: a survey of new antihistamines  
  Berdy, G.J., Abelson, M.B., George, M.A., Smith, L.M. and Giovanoni, R.L., J. Ocular Pharm., 1/1/1991
• Proper retrospective study  
  Berdy, G.J. and Roberts, C.W., J. Cataract Refract. Surg., 1/1/1989
• Join now to see all

Books/Book Chapters

• American Academy of Ophthalmology, Basic and Clinical Science Course, Section 13, Refractive Surgery 
  Chapter: Refractive Surgery in Ocular and Systemic Disease 
  Page 165 - 185Berdy, G.J.American Academy of Ophthalmology, San Francisco, CA2015
• American Academy of Ophthalmology, Basic and Clinical Science Course, Section 13, Refractive Surgery 
  Chapter: Considerations after Refractive Surgery 
  Page 187 - 195Berdy, G.J.American Academy of Ophthalmology, San Francisco, CA2015
• Albert & Jakobiec’s Principles and Practice of Ophthalmology 
  Chapter: Ocular Allergic Diseases 
  Page 89 - 95Berdy, G.J. and Berdy, S.S.Editors: Joo, S., Kau, L.K., DeFer, T.M. and Henderson, K.E..Wolters Kluwer/Lippincott, Philadelphia, PAEdition 2nd,2013
• Albert & Jakobiec’s Principles and Practice of Ophthalmology 
  Chapter: Antihistamines and mast cell stabilizers in allergic ocular disease 
  Page 265 - 279Berdy, G.J., Leonardi, A. and Abelson, M.BEditors: Albert, D.M., Miller, J.W., Azar, D.T., and Blodi, B.A..Saunders Elsevier, Inc., Philadelphia, PAEdition 3rd,2008
• The Washington Manual, Allergy, Asthma, and Immunology Subspecialty Consult 
  Chapter: Ocular Allergic Diseases 
  Page 77 - 83Berdy, G.J. and Berdy, S.S.Editors: Jost, B.C., Abdel-Hamid, K.M., Friedman, E.C. and Jani, A.L..Lippincott, Williams and Wilkins, Philadelphia, PAEdition 1st,2003
• Allergic Diseases of the Eye 
  Chapter: Mast Cells and Allergic Inflammation in the Eye 
  Page 20 - 33Berdy, G.J. and Berdy, S.S.Editors: Abelson, M.B..W. B. Saunders Company, Philadelphia, PAEdition 1st,2001
• Allergic Diseases of the Eye 
  Chapter: Immunoglobulins and Allergic Inflammation in the Eye 
  Page 69 - 78Berdy, S.S. and Berdy, G.J.Editors: Abelson, M.B..W. B. Saunders Company, Philadelphia, PAEdition 1st,2000
• Principles and Practice of Ophthalmology 
  Chapter: Antihistamines and mast cell stabilizers in allergic ocular disease 
  Page 1028 - 1042Berdy, G.J. and Abelson, M.B.Editors: Albert, D.M. and Jakobiec, F.A..W. B. Saunders Company, Philadelphia, PAEdition 1st,1993
• Join now to see all

Abstracts/Posters

• Clinical Evaluation of a New Enhanced Viscosity Eye Drop for Moderate to Severe Dry Eye Disease : A Multicenter, Double-Masked, Randomized 30-day Study
  Lievens, C., Berdy, G., Douglass, D., Montaquila, S., Lin, H., Simmons, P., Carlisle, C., Changela, M., Seifu, Y., Hollander, D. and Vehige, J., American Academy of Optometry Annual Meeting, New Orleans, LA, 1/7/2015
• Evaluation of Patients With a Strong Response to Epithelial-On Corneal Collagen Crosslinking
  Trattler, W., Buznego, C., Luchs, J., Adi, M., Rubinfeld, R.S., Berdy, G. and Perez, G., American Academy of Ophthalmology Annual Meeting, Chicago, IL, 1/10/2012
• Retrospective Evaluation of Epithelial-On Cross-Linking (CXL)
  Trattler, W., Talamo, J., Bowman, B., Letko, E., Berdy, G., Wiley, W., Flor, R., Perez, G., Littner, R., Seligson, V. and Forstot, L., European Society of Cataract and Refractive Surgery 30th Congress, Milan, Italy, 1/8/2012
• Multicenter evaluation of transepithelial corneal collagen cross linking for keratoconus and post-LASIK ectasia
  Trattler, W., Rubinfeld, R., Majmudar, P., Letko, E., Forstot, L., Perez, G., Berdy, G., Schwartz, J., Hatch, K., Kaiser, C., Bafna, S. and Wiley, W., International Society of Refractive Surgery, Orlando, FL, 1/21/2011
• Incidence of concomitant cataract and dry eye : a prospective health assessment of cataract patients’ ocular surface
  Trattler, W., Goldberg, D., Reilly, C., Packer, M., Majmudar, P., Donnenfeld, E., McDonald, M., Vukich, J., Berdy, G., Malhotra, R. and Stonecipher, K., Association for Research and Vision in Ophthalmology Annual Meeting; European Society of Cataract and Refractive Surgery 28th Congress, Ft. Lauderdale, FL, 2010; Paris, France, 2010, 1/5/2010
• Once-a-day olopatadine improves the health-related qualitity of life of allergic conjunctivitis patients
  Berdy, G., Scoper, S. V., Lichenstein, S. J., Rubin, J. M., Waycaster, C., Pasquine, T., Gross, R. D., Robertson, S., Jour. Allergy and Clin. Immunol., 1/1/2007
• Laser refractive (LASEK and PRK) surgical correction of high anisometropic myopia in amblyopic children
  Leibole, M.A., Berdy, G.J., Packwood, E., Norman, A. and Tychsen, L., Invest. Ophthalmol. Vis. Sci., 1/1/2002
• Phase 2 dose ranging efficacy trial of INS365 ophthalmic solution, a P2Y2 agonist, in patients with dry eye
  Foulks, G., Sall, K., Greenberg, M., Tauber, J., Donshik, P., Berdy, G., Sylvester, R., Yerxa, B., Crockett, S. and Kellerman, D., Invest. Ophthalmol. Vis. Sci., 1/1/2001
• Blood concentrations of cyclosporin A (CsA) during twice daily treatment of 0.05% and 0.1% cyclosporine ophthalmic emulsions in patients with moderate to severe kerato...
  Small, D.S., Acheampong, A., Reis, B., Stewart, W., Berdy, G., Epstein, R., Foerster, R., Forstot, L. and Tang-Liu, D., Invest. Ophthalmol. Vis. Sci., 1/1/2000
• A scanning electron microscopic comparison of the effects of 0.001% sodium silver chloride complex vs 0.001% benzalkonium chloride on the rabbit corneal epithelium
  Schaefer, K.M., George, M.A. and Berdy, G.J., Invest. Ophthalmol. Vis. Sci., 1/1/1992
• Comparative effects of preservative free tear substitutes on the rabbit cornea: a scanning electron microscopic evaluation
  Smith, L.M., George, M.A., Berdy, G.J. and Abelson, M.B., Invest. Ophthalmol. Vis. Sci., 1/1/1991
• Platelet activating factor induced inflammation following topical ocular challenge
  George, M.A., Smith, L.M., Berdy, G.J. and Abelson, M.B., Invest. Ophthalmol. Vis. Sci., 1/1/1990
• Characteristics of isolated guinea pig and human conjunctival mast cells
  Levene, R.B., Bateman, S.T., Berdy, G.J., Bloch, K.J. and Allansmith, M.R., Invest. Ophthalmol. Vis. Sci., 1/1/1990
• Identification of histaminase activity in human tears after conjunctival antigen challenge
  Berdy, G.J., Levene, R.B., Bateman, S.T., George, M.A., Smith, L.M. and Abelson, M.B., Invest. Ophthalmol. Vis. Sci., 1/1/1990
• The corneal epithelial effects of benzalkonium chloride compared to a new preservative, sepazonium
  Smith, L.M., George, M.A., Berdy, G.J. and Abelson, M.B., Invest. Ophthalmol. Vis. Sci., 1/1/1990
• The effects of disodium cromoglycate in a human model of acute allergic conjunctivitis
  Berdy, G.J., Smith, L.M., George, M.A. and Abelson, M.B., Invest. Ophthalmol. Vis. Sci., 1/1/1989
• The effects of a new non-steroidal antiinflammatory agent, 1% and 0.5% RMI 1068, in an animal model of anterior uveitis
  George, M.A., Greiner, J.V., Conway, J., Smith, L.M., Berdy, G.J. and Abelson, M.B., Invest. Ophthalmol. Vis. Sci., 1/1/1989
• Join now to see all

Lectures

• Ocular Surface Disease Management: Moving from Adequate to Expert 
  Multple locations, 2011, 2012, 2013, 2015, 2016, 2017 - 1/13/2017
• Refractive Surgery Complications: Prevention and Management 
  Chicago, IL, 2016; New Orleans, LA, 2017 - 1/13/2017
• Mastering Transepithelial and Epi-Off Corneal Collagen Crosslinking For Keratoconus and Post-LASIK Ectasia 
  New Orleans, LA - 1/7/2016
• Dry Eye 2008 – Do We Really Know What It Will Take to Win? 
  Atlanta, GA - 1/10/2008
• Dry Eye 2007 – Doing it better 
  Berdy, G.J. and Tauber, J. - 1/11/2007
• Strategies for Managing and Treating External Eye Disease 
  Kowloon, Hong Kong, China - 1/28/2006
• Dry Eye 2006 – The Year of the Cure 
  Las Vegas, NV - 1/14/2006
• Diagnosis and Management of Ocular Allergy: An Interactive Approach 
  New Orleans, LA, 2004; Chicago, IL, 2005; Las Vegas, NV, 2006 - 1/13/2006
• Ocular Allergy: New Treatment Options 
  Beijing, China - 1/1/2006
• Dry Eye 2005 – The Year of the Cure 
  Chicago, IL - 1/16/2005
• Management of Dry Eye and Ocular Surface Disease 
  New Orleans, LA - 1/26/2004
• New Treatment Options for Allergic Conjunctivitis 
  Busan, Korea - 1/23/2004
• Ocular Allergic Disorders: Pathogenesis, Differential Diagnosis and Treatment. Course 227 
  New Orleans, LA, 2001; Orlando, FL, 2002; Anaheim, CA, 2003 - 1/16/2003
• LASIK Pearls and Pitfalls: How Not to Make the Same Mistake Twice. Course 331 
  New Orleans, LA, 2001; Orlando, FL, 2002 - 1/22/2002
• Symposium: The Eyes of Texas: Advances in the Research of Ocular Allergy Agents. Mast Cell Heterogeneity and Eosinophils: Clinical Implications in the Management of Oc... 
  San Antonio, TX - 1/17/2002
• LASIK Complications: How Not to Make the Same Mistake Twice 
  Kohler, WI - 1/11/2001
• LASIK Pearls in Surgical Management 
  1/9/2001
• New Allergy Therapy for the New Millenium 
  Wichita, KS - 1/18/2000
• Complications of LASIK Surgery 
  Des Moines, IA - 1/15/2000
• Ocular Allergy in the Senior Patient 
  Cancun, Mexico - 1/13/2000
• Practical Pearls in Refractive Surgery 
  Chicago, IL - 1/4/2000
• Ocular allergies: a clinical view to management 
  1/1/2000
• Decision Maker. Choosing the most appropriate medication for the allergy patient: making decisions between drugs on the market now and in the near future 
  1/1/2000
• Wegener’s Granulomatosis: Diagnosis and Management 
  1/13/1998
• Photorefractive Keratectomy: Techniques of Surgery 
  Branson, MO - 1/6/1998
• Join now to see all